
    
      A phase 2, multi-center, double-blind, randomized, vehicle-controlled study to be conducted
      in approximately 170 non immunocompromised adult subjects with interdigital tinea pedis.
      Subjects will apply the investigational product (IP) (SB208 or Vehicle Gel) to the
      interdigital areas and all affected and immediate surrounding areas of one or both feet once
      daily for 2 weeks, followed by a 4-week post-treatment observation period.
    
  